# CAI (Caris Life Sciences, Inc.) - SEC EDGAR Financial Statements

> Caris Life Sciences, Inc. reported $1.05B in revenue and net income of $96.06M for the trailing twelve months ended September 30, 2026 (up 27.0% year over year), with a 13.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/CAI
- Markdown: https://convexityos.com/fundamentals/CAI.md
- SEC CIK: 0002019410
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002019410&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.05B | +27.0% YoY |
| Operating Income | TTM | $139.9M | 13.4% margin |
| Net Income | TTM | $96.06M | 9.2% net margin |
| Diluted EPS | TTM | $0.33 | Split-adjusted |
| Free Cash Flow | TTM | $66.89M | 6.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $102.1M | Total debt: $463.0M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $812.0M | $412.3M | $306.1M |
| Research & Development | $101.6M | $113.9M | $116.9M |
| Selling, General & Admin | $392.5M | $322.0M | $292.0M |
| **Operating Income** | $45.11M | -$257.1M | -$319.6M |
| **EBITDA** | $67.73M | -$208.2M | -$270.6M |
| Interest Income | $16.50M | $7.12M | $11.26M |
| Interest Expense | $56.85M | $50.02M | $31.61M |
| Income Before Tax | -$68.09M | -$281.9M | -$341.4M |
| Income Tax Expense | $0 | $0 | $0 |
| **Net Income** | -$68.09M | -$281.9M | -$341.4M |
| Basic EPS | -$3.22 | -$10.66 | -$13.24 |
| **Diluted EPS** | -$3.22 | -$10.66 | -$13.24 |
| Basic Shares Outstanding | 167.2M | 35.5M | 34.9M |
| Diluted Shares Outstanding | 167.2M | 35.5M | 34.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $275.4M | $263.7M | $216.2M | $292.9M | $216.8M | $181.4M | $120.9M | $101.6M |
| Research & Development | $33.84M | $32.36M | $31.32M | $31.84M | $21.62M | $25.05M | $23.07M | $27.64M |
| Selling, General & Admin | $129.1M | $120.3M | $104.8M | $100.7M | $93.24M | $106.6M | $91.95M | $77.61M |
| **Operating Income** | $19.32M | $26.93M | $5.28M | $88.41M | $32.64M | -$17.99M | -$57.95M | -$60.84M |
| **EBITDA** | $25.92M | $33.43M | $10.35M | $92.70M | $37.54M | -$11.59M | -$50.91M | -$50.34M |
| Interest Income | $6.33M | $6.82M | $6.83M | $7.01M | $7.36M | $1.62M | $503K | $1.74M |
| Interest Expense | $9.25M | $9.23M | $12.81M | $11.36M | $13.51M | $19.21M | $12.78M | $13.80M |
| Income Before Tax | $16.87M | -$614K | -$644K | $81.96M | $24.32M | -$71.79M | -$102.6M | -$67.73M |
| Income Tax Expense | $1.62M | $23K | -$134K | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | $15.25M | -$637K | -$510K | $81.96M | $24.32M | -$71.79M | -$102.6M | -$67.73M |
| Basic EPS | $0.05 | $0.00 | $0.00 | -- | $0.09 | -$7.97 | -$3.57 | -$2.59 |
| **Diluted EPS** | $0.05 | $0.00 | $0.00 | -- | $0.08 | -$7.97 | -$3.57 | -$2.59 |
| Basic Shares Outstanding | 283.9M | 282.9M | 282.6M | -- | 282.1M | 64.9M | 35.6M | 35.6M |
| Diluted Shares Outstanding | 295.1M | 282.9M | 282.6M | -- | 297.2M | 64.9M | 35.6M | 35.6M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $796.3M | $63.95M |
| Short-Term Investments | $2.29M | $2.20M |
| **Cash & Short-Term Investments** | $798.6M | $66.15M |
| Accounts Receivable, Net | $112.1M | $88.24M |
| Other Current Assets | $2.35M | $6.71M |
| **Total Current Assets** | $997.8M | $215.7M |
| Property, Plant & Equipment, Net | $63.17M | $67.82M |
| Goodwill | $19.34M | $19.34M |
| Other Non-Current Assets | $45.35M | $40.84M |
| **Total Non-Current Assets** | $127.9M | $128.0M |
| **Total Assets** | $1.13B | $343.7M |
| Accounts Payable | $39.21M | $27.79M |
| Short-Term Debt | $169K | $60.09M |
| Deferred Revenue (Current) | $24.49M | $7.47M |
| **Total Current Liabilities** | $127.1M | $165.4M |
| Long-Term Debt | $378.8M | $319.4M |
| Deferred Revenue (Non-Current) | $0 | -- |
| Other Non-Current Liabilities | $42.39M | $44.42M |
| **Total Non-Current Liabilities** | $421.2M | $455.5M |
| **Total Liabilities** | $548.4M | $620.9M |
| **Total Debt (incl. Leases)** | $428.2M | $424.6M |
| Common Stock | $283K | $38K |
| Retained Earnings | -$2.55B | -$2.47B |
| Accumulated Other Comp. Income | $936K | $210K |
| **Total Stockholders' Equity** | $577.3M | -$2.50B |
| Total Equity | $577.3M | -$2.50B |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | $819.9M | $796.3M | $753.2M | $718.9M | $63.95M |
| Short-Term Investments | $102.1M | $102.2M | $2.31M | $2.29M | $2.27M | $2.25M | $2.20M |
| **Cash & Short-Term Investments** | -- | -- | $822.2M | $798.6M | $755.5M | $721.2M | $66.15M |
| Accounts Receivable, Net | $133.3M | $116.9M | $90.52M | $112.1M | $26.70M | $50.89M | $88.24M |
| Other Current Assets | $4.91M | $5.11M | $4.29M | $2.35M | $2.58M | $2.55M | $6.71M |
| **Total Current Assets** | $1.07B | $1.06B | $1.01B | $997.8M | $854.2M | $833.3M | $215.7M |
| Property, Plant & Equipment, Net | $102.3M | $95.72M | $82.67M | $63.17M | $64.00M | $61.31M | $67.82M |
| Goodwill | $19.34M | $19.34M | $19.34M | $19.34M | $19.34M | $19.34M | $19.34M |
| Other Non-Current Assets | $66.72M | $56.73M | $46.20M | $45.35M | $46.98M | $41.08M | $40.84M |
| **Total Non-Current Assets** | $188.4M | $171.8M | $148.2M | $127.9M | $130.3M | $121.7M | $128.0M |
| **Total Assets** | $1.26B | $1.23B | $1.16B | $1.13B | $984.6M | $955.1M | $343.7M |
| Accounts Payable | $63.84M | $85.99M | $69.80M | $39.21M | $29.00M | $28.73M | $27.79M |
| Short-Term Debt | $89K | $178K | $173K | $169K | $164K | $95K | $60.09M |
| Deferred Revenue (Current) | $18.37M | $20.52M | $24.97M | $24.49M | $2.79M | $5.34M | $7.47M |
| **Total Current Liabilities** | $158.9M | $191.4M | $143.9M | $127.1M | $86.03M | $90.18M | $165.4M |
| Long-Term Debt | $393.2M | $393.0M | $381.4M | $378.8M | $376.3M | $373.6M | $319.4M |
| Deferred Revenue (Non-Current) | $552K | $539K | -- | $0 | -- | -- | -- |
| Other Non-Current Liabilities | $64.02M | $53.48M | $43.60M | $42.39M | $43.88M | $38.36M | $44.42M |
| **Total Non-Current Liabilities** | $457.2M | $446.4M | $425.0M | $421.2M | $420.2M | $412.0M | $455.5M |
| **Total Liabilities** | $616.1M | $637.9M | $568.9M | $548.4M | $506.2M | $502.2M | $620.9M |
| **Total Debt (incl. Leases)** | $463.0M | $452.4M | $431.0M | $428.2M | $426.7M | $419.0M | $424.6M |
| Common Stock | $287K | $283K | $284K | $283K | $283K | $282K | $38K |
| Retained Earnings | -$2.53B | -$2.55B | -$2.55B | -$2.55B | -$2.63B | -$2.66B | -$2.47B |
| Accumulated Other Comp. Income | -$105K | $529K | $893K | $936K | $748K | $669K | $210K |
| **Total Stockholders' Equity** | $639.5M | $591.7M | $593.5M | $577.3M | $478.4M | $452.9M | -$2.50B |
| Total Equity | $639.5M | $591.7M | $593.5M | $577.3M | $478.4M | $452.9M | -$2.50B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$68.09M | -$281.9M | -$341.4M |
| Depreciation & Amortization | $22.61M | $48.91M | $49.00M |
| Stock-Based Compensation | $70.01M | $18.64M | $15.24M |
| Change in Receivables | -$29.79M | -$33.82M | -$15.08M |
| Change in Payables | $11.04M | -$226K | $7.17M |
| **Operating Cash Flow** | $83.16M | -$245.2M | -$276.1M |
| Capital Expenditure | -$16.26M | -$8.44M | -$22.32M |
| **Free Cash Flow** | $66.89M | -$253.6M | -$298.4M |
| Purchases of Investments | $0 | $0 | -$63.40M |
| **Investing Cash Flow** | -$16.26M | $52.93M | $214.8M |
| Share Repurchases | -$113K | $0 | $0 |
| **Financing Cash Flow** | $665.0M | $200.3M | $10.13M |
| **Net Change in Cash** | $732.0M | $8.02M | -$51.13M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $15.25M | -$637K | -$510K | $81.96M | $24.32M | -$71.79M | -$102.6M | -$67.73M |
| Depreciation & Amortization | $6.60M | $6.50M | $5.07M | $4.29M | $4.90M | $6.40M | $7.04M | $10.50M |
| Stock-Based Compensation | $18.50M | $22.22M | $15.87M | $13.37M | $13.65M | $28.29M | $14.69M | $4.72M |
| Change in Receivables | -$16.43M | -$26.37M | $21.62M | -$91.02M | $24.19M | $29.13M | $7.91M | -- |
| Change in Payables | -$21.59M | $23.26M | $16.37M | $12.23M | $729K | -$186K | -$1.74M | -- |
| **Operating Cash Flow** | -$22.25M | $28.48M | $32.88M | $44.78M | $62.42M | $7.29M | -$31.34M | -- |
| Capital Expenditure | -- | -- | -$10.34M | -$5.09M | -$7.09M | -$1.39M | -$2.69M | -- |
| **Free Cash Flow** | -- | -- | $22.53M | $39.69M | $55.33M | $5.90M | -$34.03M | -- |
| **Investing Cash Flow** | -$17.47M | -$122.2M | -$10.34M | -$5.09M | -$7.09M | -$1.39M | -$2.69M | -- |
| Share Repurchases | -$10.01M | -$21.36M | $0 | -$91K | $0 | $0 | -$22K | -- |
| **Financing Cash Flow** | $14.23M | -$36.90M | $824K | $3.40M | -$21.10M | $681.4M | $1.28M | -- |
| **Net Change in Cash** | -$25.59M | -$130.6M | $23.35M | $43.06M | $34.30M | $687.4M | -$32.74M | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Operating Margin** | 5.6% | -62.4% | -104.4% |
| **Net Profit Margin** | -8.4% | -68.4% | -111.5% |
| Return on Equity (ROE) | -11.8% | -- | -- |
| Return on Assets (ROA) | -6.0% | -82.0% | -- |
| Current Ratio | 7.85x | 1.30x | -- |
| Quick Ratio | 7.16x | 0.93x | -- |
| Debt to Equity | 0.74x | -- | -- |
| **Revenue Growth (YoY)** | +97.0% | +34.7% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 13.4% | 15.5% | 11.9% | 5.6% | -- | -- | -- | -- |
| **Net Profit Margin** | 9.2% | 10.6% | 3.7% | -8.4% | -- | -- | -- | -- |
| Return on Equity (ROE) | 15.0% | 17.8% | 5.7% | -11.8% | -- | -- | -- | -- |
| Return on Assets (ROA) | 7.7% | 8.6% | 2.9% | -6.0% | -- | -- | -- | -- |
| Current Ratio | 6.71x | 5.53x | 7.05x | 7.85x | 9.93x | 9.24x | -- | -- |
| Quick Ratio | -- | -- | 6.34x | 7.16x | 9.09x | 8.56x | -- | -- |
| Debt to Equity | 0.72x | 0.76x | 0.73x | 0.74x | 0.89x | 0.93x | -- | -- |
| **Revenue Growth (YoY)** | +27.0% | +45.4% | +78.8% | -- | +113.4% | +81.3% | -- | -- |
| Operating Income Growth (YoY) | -40.8% | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -37.3% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -44.4% | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -135.6% | +290.7% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
